17.08.2013 Views

PEC12-25 CAPEC-PROCESS Industrial Consortium ... - DTU Orbit

PEC12-25 CAPEC-PROCESS Industrial Consortium ... - DTU Orbit

PEC12-25 CAPEC-PROCESS Industrial Consortium ... - DTU Orbit

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>CAPEC</strong>-<strong>PROCESS</strong><br />

3.4 External PhD-students (projects)<br />

Klaus Reinholdt Nyhuus<br />

Hansen (KRNH)<br />

<strong>DTU</strong> Management - <strong>CAPEC</strong><br />

satisfied product attributes is the main goal of this study. In<br />

order to achieve the objectives, four key tasks are needed.<br />

Firstly, the general chemical blending problem is formulated.<br />

Then, the property models are identified to estimate the pure and<br />

mixture properties. The unavailable property models are being<br />

developed by using experimental data and appropriate modeling<br />

tools. Next, the chemical mixture/blend algorithm is developed<br />

in order to find the best mixture/blend using suitable solution<br />

strategy. Finally, the developed mixture/blend algorithm is<br />

applied to case studies and validated with experimental data.<br />

Supervisors: RAG, JW, KVG<br />

Start: 01-06-2010; End: 01-05-2013<br />

Research area: A, B, C<br />

New product introduction for the pharmaceutical industry<br />

It is well known, that the pharmaceutical industry is struggling<br />

with increasing cost and length of R&D projects. Earnings of a<br />

drug drop drastically after patent expiration. Thus, the industry<br />

spends much effort on reducing Time-to-Market. However, a<br />

suitable methodology for planning operations immediately prior<br />

to launch is especially lacking.<br />

Due to strict cleaning requirements, production setups are very<br />

long. Production volumes are thus large and intermittent and the<br />

entire supply chain becomes rigid and inflexible. Besides<br />

forecast uncertainty, which is difficult for new products, other<br />

risks and uncertainties from carrying out reimbursement<br />

negotiations with authorities in each market e.g. reimbursement<br />

levels and product price can also disrupt the execution of a<br />

market launch.<br />

In this project a MILP-based methodology for planning<br />

operations before and during market launch is developed, which<br />

fits into the S&OP structure of pharmaceutical companies while<br />

considering risks and uncertainties. The methodology should be<br />

connected to the existing methodologies; pipeline planning,<br />

capacity planning and production planning.<br />

Supervisors: Renzo Akkerman (<strong>DTU</strong>-MAN); Martin Grunow;<br />

RaG<br />

Start: 01-09-2009; End: 31-08-2012<br />

Research area: D, E<br />

40

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!